My opinion about Ampligen has always been that those who are currently taking the drug and wish to continue should be allowed to do so, but that the drug company that produces it should have to go through the usual procedures to show efficacy before new patients are brought in. I respect Dr Peterson, but when only one doctor in the US can say that he can predict responders, that’s a red flag for me. I have known patients who have mortgaged their homes and gone into debt to move to Lake Tahoe and pay the tremendous cost of this drug. I would not encourage anyone to do so until the new leadership of the drug company answers the questions that were raised at the FDA hearing and does further testing to show efficacy. I think that it’s great that Dr Hanson is looking at Dr Peterson’s accumulated data, but I believe that she’s just looking for clues to follow, not trying to evaluate the drug. Dr Peterson says that the blood work that he obtains from his patients indicates whether or not his patients are improving. I would like a second set of eyes on that data. For people like me who have been around for a long time, opinions about Ampligen vary tremendously. My first support group leader was a part of Dr Cheney’s first trial group. My own ME/CFS doctor looked into participating in an Ampligen trial back in the early ‘90s. He decided against it and I agreed with that decision. But we are both fairly conservative about medical decisions. In my old in-person support group days, we used to joke that we would only get excited about a treatment when we heard the magic words, “And then I went back to work.” I do not think that I know anyone who has participated in Dr Peterson’s Ampligen trials who has been able to discontinue Ampligen, go back their former lives, and continue to be healthy enough to work for longer than a year without relapsing.